Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...

Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $45.42 which represents a slight increase of $0.79 or 1.77% from the prior close of $44.63. The stock opened at $45.17 and ...

The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...

Check the time stamp on this data. Updated AI-Generated Signals for Tandem Diabetes Care Inc. (TNDM) available here: TNDM.

TANDEM DIABETES CARE INC (TNDM) is a mid-cap value stock in the Medical Equipment & Supplies industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the ...

Tandem Diabetes Care(NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit the headlines investors piled into the stock. At the end of the day the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Tandem ...

Stifel reiterated its Buy rating on shares of Tandem Diabetes Care (NASDAQ:TNDM), with a consistent price target of $60.00. The firm's monthly Mobi survey, conducted in July,... On Thursday ...

Tandem Diabetes TNDM is gaining from continued product innovations. Yet, rising costs put pressure on margins. The stock carries a Zacks Rank #3 (Hold). Tandem Diabetes is driving transformative ...

Investing.com - Tandem Diabetes Care (NASDAQ: TNDM) reported third quarter EPS of $-0.51, $0.03 worse than the analyst estimate of $-0.48. Revenue for the quarter came in at... Tandem Diabetes ...